CEL-SCI
Vienna
About CEL-SCI
CEL-SCI Corporation is a biotechnology company. CEL-SCI is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. The Company's core capabilities include: drug discovery, research, development and manufacturing of complex biological substances.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $119.3M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2025)
- Ticker: nysemkt:CVM
- Website: cel-sci.com
- Phone: 7035069471
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/cel-sci-63260 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.